Tevogen TVGN
NASDAQ TVGN
$6.53 -0.17 (-2.54%)
At close: Oct 23, 2026 · 4:00 PM EDT

Tevogen (TVGN) Receivables - Other (2023 - 2026)

Updated

Tevogen (TVGN) reported Receivables - Other of $158,819 for Q2 2026, unchanged from $158,819 a year earlier and unchanged from the prior quarter.

Analysis

Tevogen (TVGN) Receivables - Other (2023 - 2026) Analysis & Trends

Dating back to Q4 2023, Tevogen's Receivables - Other record includes 11 quarters.

  • By year, Receivables - Other came in at $158,819 in FY2024 (-53.9%) and $344,500 in FY2023.
  • Five-year quarterly Receivables - Other spans a low of $158,819 in Q1 2024 and a high of $344,500 in Q4 2023.
  • Per Business Quant data, the three quarters before Q2 2026 came in at $158,819 (Q1 2026), $158,819 (Q4 2025) and $158,819 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn
10 Tevogen 27.79 Mn 27.79 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 158,819.00
Mar 31, 2026 158,819.00
Dec 31, 2025 158,819.00
Sep 30, 2025 158,819.00
Jun 30, 2025 158,819.00
Mar 31, 2025 158,819.00
Dec 31, 2024 158,819.00
Sep 30, 2024 158,819.00
Jun 30, 2024 158,819.00
Mar 31, 2024 158,819.00
Dec 31, 2023 344,500.00
API Access

Tevogen Receivables - Other API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-other&ticker=TVGN&period=max&api_key=YOUR_API_KEY